Class I medical rehabilitation aids (manual wheelchairs, orthopedic supports, crutches, basic training equipment, etc.) are experiencing concentrated import policy benefits globally as the world's population ages and the demand for rehabilitation rises. This condensed guide helps importers reduce costs and increase competitiveness by outlining key preferential policies across important markets with official sources.
I. Europe & US: Tariff Cuts + VAT Exemptions
Mature markets with robust policies focusing on cost reduction and vulnerable group protection.
1. EU
Per Council Regulation (EEC) No 2913/92, Class I aids circulate tariff-free within the EU (28 member states + EEA). For non-EU imports (e.g., China), most face 0-3% tariffs per EU TARIC (verify via http://madb.europa.eu/madb/euTariffs.htm). Germany, France, and the UK offer VAT perks: France applies 2.1% VAT (vs. 20% standard) for disability-specific aids; the UK grants 0% VAT via self-declaration (no medical certs). Class I products are exempt from Notified Body (NB) certification—only EC REP entrustment and EUDAMED registration (1-2 months) are needed. Note: EU Implementing Regulation 2025/1197 restricts Chinese firms in public procurement; check compliance first.
2. US
Under the Nairobi Protocol, disability-specific Class I aids (diabetic rehab gear, mobility crutches) enjoy duty-free import. Per CBP’s HTS, most others have ≤2% tariffs, with basics (grip strengtheners) at 0%. FDA exempts Class I from 510(k) pre-market notification—only FDA registration, product listing, and US Agent appointment are required. Annual renewal (＜$500) maintains validity.
3. South America
South America's policy framework centers on free trade agreements (FTAs): As a member of Mercosur (Southern Common Market), Brazil imposes zero tariffs on Class I aids traded among member states. For core categories imported from China, preferential tariffs are available under the Generalized System of Preferences (GSP) (verify via Brazil's customs official website). Argentina implements low tariffs and simplified registration for people's livelihood-related aids, with details subject to the official regulations of Argentina's Ministry of Economy.
II.Middle East: Dual Relief on Tariffs & VAT, Focus on Livelihood Needs
Many Middle Eastern countries attract high-quality imported products through tax incentives to fill gaps in local rehabilitation medical care.
The UAE offers VAT exemptions for Class I rehabilitation aids directly related to medical services under its VAT Law and amendments, with core categories subject to tariffs as low as 0-5%. Regional trade tariff preferences apply among some Gulf Cooperation Council (GCC) member states. Turkey's Presidential Decision No. 9126 of 2024 explicitly includes Class I rehabilitation aids in preferential medical product categories, applying a 10% VAT rate (regular rate 20%). Saudi Arabia imposes low tariffs on medical necessities, with most Class I aids subject to a standard 5% rate and zero tariffs for some. Qatar actively imports rehabilitation aids due to limited local production, with policies tilted toward the medical sector. Egypt applies low tariffs to livelihood-related aids, with VAT levied in accordance with special medical product standards (verify via Egypt's Tax Authority official website).
Ⅲ. Russia: VAT Exemption + Low Tariffs, Clear Policy Dividends
The revised "List of Medical Devices Exempt from VAT" by Russia's Ministry of Health has been officially promulgated. Class I products such as orthopedic fixation systems and dedicated rehabilitation accessories are explicitly included in the VAT exemption scope. Eligible imported products enjoy tariffs as low as 0-5%; enterprises must verify product eligibility against Russia's customs codes and official duty-free lists.
For compliance, online registration in accordance with the requirements of Russia's Federal Service for Supervision of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) ensures efficient customs clearance. In emerging markets, Uzbekistan's free economic zones offer 3-10 years of full exemptions from tariffs and corporate income tax for imported production equipment and raw materials for Class I aids, with an import dependence rate of 70%. Kazakhstan requires NMRK certification for imported medical devices; compliance grants access to relevant import facilitation policies.
Ⅳ. Japan, South Korea & Southeast Asia Markets: Low Tariffs as Core, Clear Key Policies
Japan: Class I aids are subject to tariffs of 0-2%, requiring simplified registration with the Pharmaceuticals and Medical Devices Agency (PMDA). South Korea: Core categories enjoy graded tariff preferences with rates of 0-3%. Southeast Asia: Many countries reduce tariffs via FTAs; Vietnam, Indonesia, etc., offer zero tariffs plus VAT preferences for core categories. Details are subject to each country's official policies.
Ⅴ. Key General Guidelines for Enjoying Preferences (Official Policy Guidance)
1. Compliance first: Complete target market registration (EU: EC REP+EUDAMED; US: FDA; Japan: PMDA).
2. Secure Certificate of Origin (Form A/E for China-EU, Form E for ASEAN, ChAFTA COO).
3. Match eligibility via official channels (EU MDR, US FDA database, Japan PMDA guidelines).
Ⅵ. Company's Export Advantages, Qualifications & Certifications
With a thorough compliance system and integrated service capabilities, our company specializes in exporting Class I medical rehabilitation assistive devices. Our main advantages are:
Complete Certifications: MDMA, FDA, CE (MDR), ISO 13485
Professional Services: Committed service and compliance teams
Stable Supply Chain: Product quality and delivery efficiency are guaranteed by large-scale production facilities and end-to-end quality control systems.
Additionally, we provide foreign businesses with specialized product supply services. We welcome foreign partners to get in touch with us on email mandy@sunshinehc.net at any time. Our official website has comprehensive qualification documents, pertinent certificates, and company details.
